Roche and Eppendorf, both companies offering systems for use in life-science research, announced that they have entered into a license agreement for use of the melting curve analysis. Under the terms of the agreement, Eppendorf obtains from Roche a non-exclusive license to use, develop and sell products based on Melting Curve Analysis; excluded from the rights is the use in human and veterinary in vitro diagnostics.
Financial terms of the agreement were not disclosed.
The melting curve analysis is a technique for analysis of PCR products. After PCR, the resulting PCR product is slowly heated. Each double-stranded DNA has its own specific melting temperature (Tm), which is defined as the temperature at which 50% of the DNA becomes single stranded. By measurement of Tm, the DNA can be easily identified.
"We regard the licensing of the melting curve analysis technique as an important contribution to further developing this technology in the life science field," states Manfred Baier, Head of Roche Applied Science, a business area of Roche Diagnostics.
"This agreement provides both companies, Eppendorf and Roche Diagnostics, with potential for continuing their success in this field," adds Michael Schroeder, Board Member Sales and Marketing Eppendorf AG.,
In July this year, Roche and Eppendorf already signed a cooperation agreement in the field of protein expression.
About Eppendorf
The Eppendorf Group, based in Hamburg, Germany, is a leading supplier of systems and research tools for the global life science industry with own sales organizations in many high potential markets and strong presence through distribution partners worldwide. Eppendorf manufactures instruments and consumables for liquid handling including solutions for automation as well as a range of PCR and realtime PCR products. Eppendorf is a market leader in microcentrifugation with a full range of products for many areas of research. Other products comprise sample preparation, detection and cell technology research. Many of its products such as certain plastic consumables, pipettes and centrifuges are considered market leading standards. In fiscal 2005, Eppendorf employed approximately 1,800 people worldwide and achieved sales of 321 million Euros (approx. 400 million US Dollars) which represents a growth rate of approximately 12% compared to prior year results.More information on Eppendorf is available at www.eppendorf.com.
Financial terms of the agreement were not disclosed.
The melting curve analysis is a technique for analysis of PCR products. After PCR, the resulting PCR product is slowly heated. Each double-stranded DNA has its own specific melting temperature (Tm), which is defined as the temperature at which 50% of the DNA becomes single stranded. By measurement of Tm, the DNA can be easily identified.
"We regard the licensing of the melting curve analysis technique as an important contribution to further developing this technology in the life science field," states Manfred Baier, Head of Roche Applied Science, a business area of Roche Diagnostics.
"This agreement provides both companies, Eppendorf and Roche Diagnostics, with potential for continuing their success in this field," adds Michael Schroeder, Board Member Sales and Marketing Eppendorf AG.,
In July this year, Roche and Eppendorf already signed a cooperation agreement in the field of protein expression.
About Eppendorf
The Eppendorf Group, based in Hamburg, Germany, is a leading supplier of systems and research tools for the global life science industry with own sales organizations in many high potential markets and strong presence through distribution partners worldwide. Eppendorf manufactures instruments and consumables for liquid handling including solutions for automation as well as a range of PCR and realtime PCR products. Eppendorf is a market leader in microcentrifugation with a full range of products for many areas of research. Other products comprise sample preparation, detection and cell technology research. Many of its products such as certain plastic consumables, pipettes and centrifuges are considered market leading standards. In fiscal 2005, Eppendorf employed approximately 1,800 people worldwide and achieved sales of 321 million Euros (approx. 400 million US Dollars) which represents a growth rate of approximately 12% compared to prior year results.More information on Eppendorf is available at www.eppendorf.com.
